USPTO serial 79282351
QI LU
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 15, 2021
- Examiner
- KON, ELISSA GARBER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with QI LU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dana Stewart-Mekdara
Dana Stewart-Mekdara Global Trademarks, Inc.505 S. Villa Real Drive, Suite 102Anaheim, CA 92807UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Pharmaceutical preparations for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Drugs for medical purposes for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Ointments for pharmaceutical purposes for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Crude drugs, namely, extracts of hops for pharmaceutical purposes, eucalyptus for pharmaceutical purposes, Mint for pharmaceutical purposes, Malt for pharmaceutical purposes, Pepsins for pharmaceutical purposes, Thymol for pharmaceutical purposes, Turpentine for pharmaceutical purposes, Flaxseed for pharmaceutical purposes, Ferments for pharmaceutical purposes, Cytostatics for pharmaceutical purposes, Balms for pharmaceutical purposes, Digestives for pharmaceutical purposes, Iodine for pharmaceutical purposes, Alcohol for pharmaceutical purposes, and Starch for pharmaceutical purposes, all for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Cultures of microorganisms for medical or veterinary use; Nutritive substances for microorganisms for medical purposes; Veterinary preparations for pig, farm animals, companion animals, pets, ruminants, namely, vaccine, anti-parasite, antipyretic, analgesic, anti-inflammatory, antibiotic, disinfectants and feed additive preparations; Medicines for veterinary purposes for pig, farm animals, companion animals, pets, ruminants, namely, vaccine, anti-parasite, antipyretic, analgesic, anti-inflammatory, antibiotic, disinfectants and feed additive preparations; antibiotics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QILU PHARMACEUTICAL CO., LTD.
- Other trademarks owned by QILU PHARMACEUTICAL CO., LTD.
- Other trademarks owned by QILU PHARMACEUTICAL CO., LTD.
- Other trademarks in Class 005
- Similar marks named QI LU
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 29, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 30, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 29, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 15, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 15, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 28, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 10, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 10, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 22, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 22, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 17, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 16, 2021 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 3, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 3, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 3, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 3, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2021 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 3, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |